Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $3.2B | $135M | $22M | $104M | 2.9% | 56.4% | -47.9% |
| 2024 | $2.0B | $142M | $43M | $44M | 6.1% | 46.7% | -28.9% |
| 2023 | $1.4B | $124M | $61M | $40M | 9.9% | 21.2% | 34.4% |
| 2022 | $1.1B | $112M | $45M | $59M | 8.3% | - | - |
| 2021 | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 1,144.16 | 1,386.66 | 2,034.54 | 3,181.77 |
| Cost Of Revenue | - | 944.68 | 1,171.70 | 1,763.15 | 2,840.24 |
| Gross Profit | - | 199.48 | 214.96 | 271.39 | 341.53 |
| Operating Expense | - | 95.21 | 130.34 | 182.04 | 263 |
| Operating Income | - | 104.26 | 84.61 | 89.35 | 78.53 |
| EBITDA | - | 112.08 | 123.69 | 141.84 | 135.28 |
| EBIT | - | 94.54 | 105.94 | 113.92 | 89.53 |
| Pretax Income | - | 86.62 | 89.84 | 80.82 | 39.61 |
| Tax Provision | - | 40.88 | 31.99 | 30.89 | 15.53 |
| Net Income | - | 45.17 | 60.72 | 43.15 | 22.49 |
| Net Income Common Stockholders | - | 45.17 | 60.72 | 43.15 | 22.49 |
| Total Expenses | - | 1,039.90 | 1,302.05 | 1,945.19 | 3,103.24 |
| Interest Expense | - | 7.92 | 16.10 | 33.10 | 49.93 |
| Interest Income | - | 1.98 | 14.21 | 14.51 | 12.16 |
| Selling General And Administration | - | 77.67 | 112.60 | 154.11 | 217.26 |
| Normalized EBITDA | - | 133.35 | 128.27 | 141.11 | 135.35 |
| Normalized Income | - | 61.98 | 63.67 | 42.70 | 22.53 |
| Market Cap | 1,878.66 | 1,878.66 | 1,878.66 | 1,878.66 | 1,878.66 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Astrana Health, Inc.this co. | ASTH | $1.6B | 83.54β premium | 2.41 | 2.9% | 18.68 |
| Amylyx Pharmaceuticals, Inc. | AMLX | $1.7B | - | 5.62 | -47.4% | -9.25 |
| Nurix Therapeutics, Inc. | NRIX | $1.7B | - | 3.57 | -49.1% | -4.02 |
| Sionna Therapeutics, Inc. | SION | $1.7B | - | 5.46 | -24.5% | -16.50 |
| Agios Pharmaceuticals, Inc. | AGIO | $1.7B |
| - |
| - |
| - |
| - |
| - |
| - |
| 1.37 |
| -34.6% |
| -1.37 |
| Healthcare Services Group, Inc. | HCSG | $1.6B | 26.18 | 3.03 | 11.6% | 16.59 |
| Innoviva, Inc. | INVA | $1.6B | 6.44 | 1.49 | 23.1% | 3.96 |
| Rapport Therapeutics, Inc. | RAPP | $1.6B | - | 3.25 | -23.0% | -8.85 |
| Progyny, Inc. | PGNY | $1.6B | 25.43 | 2.88 | 11.3% | 15.56 |
| Peer Median | - | 25.43 | 3.14 | -23.8% | -2.69 | |